BRIEF published on 12/17/2025 at 07:35, 2 days 9 hours ago Sanofi publie son aide-mémoire pour le quatrième trimestre 2025 Sanofi Modélisation Financière Aide Mémoire 4e Trimestre 2025 Tourné Vers L'avenir
BRIEF published on 12/17/2025 at 07:35, 2 days 9 hours ago Sanofi Releases Q4 2025 Aide Mémoire Sanofi Financial Modeling Aide Mémoire Q4 2025 Forward-Looking
BRIEF published on 12/17/2025 at 07:35, 2 days 9 hours ago Sanofi publishes the document "Q4 2025 Quick Reference Guide" Financial Results Investors Sanofi Q4 2025 Modeling
BRIEF published on 12/17/2025 at 07:35, 2 days 9 hours ago Sanofi publie le document « Q4 2025 Aide mémoire » Résultats Financiers Investisseurs Sanofi Modélisation Q4 2025
PRESS RELEASE published on 12/17/2025 at 07:30, 2 days 9 hours ago Press release: Availability of the Q4 2025 Aide memoire Sanofi announces availability of Q4 2025 Aide memoire on the company's website for financial modeling purposes. Q4 2025 results to be published on January 29, 2026 Sanofi Results Aide Mémoire Financial Modelling Q4 2025
PRESS RELEASE published on 12/17/2025 at 07:30, 2 days 9 hours ago Communiqué de presse : Mise en ligne du document «Q4 2025 Aide mémoire » Sanofi annonce la mise en ligne du document 'Q4 2025 Aide mémoire' pour assister la communauté financière dans la modélisation des résultats trimestriels Communication Financière Résultats Trimestriels Sanofi Document Q4 2025
BRIEF published on 12/15/2025 at 07:10, 4 days 10 hours ago Sanofi : résultats de l'étude PERSEUS sur le tolébrutinib décevants Sclérose En Plaques Sanofi Tolebrutinib Étude PERSEUS Résultats D'étude
BRIEF published on 12/15/2025 at 07:10, 4 days 10 hours ago Sanofi Halts Pursuit of Regulatory Registration for Tolebrutinib in PPMS Multiple Sclerosis Tolebrutinib PPMS Trial PERSEUS Study Sanofi R&D
BRIEF published on 12/15/2025 at 07:10, 4 days 10 hours ago Sanofi renonce à l'autorisation de mise sur le marché du tolebrutinib dans le traitement de la SEP progressive primaire Sclérose En Plaques Tolebrutinib Essai PPMS Étude PERSEUS Recherche Et Développement Chez Sanofi
BRIEF published on 12/15/2025 at 07:10, 4 days 10 hours ago Sanofi: PERSEUS study results on tolebrutinib disappointing Study Results Multiple Sclerosis Sanofi Tolebrutinib PERSEUS Study
Published on 12/19/2025 at 14:40, 2 hours 31 minutes ago Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 3 hours 41 minutes ago Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Published on 12/19/2025 at 13:30, 3 hours 41 minutes ago DataMetrex Announces Closing of Yuzu Payment Processing Solution Acquisition
Published on 12/19/2025 at 13:30, 3 hours 41 minutes ago Sterling Metals Provides Year End Update to Stakeholders
Published on 12/19/2025 at 13:05, 4 hours 6 minutes ago Roxmore Resources Begins Trading on the OTCQX Best Market in the United States
Published on 12/19/2025 at 16:51, 20 minutes ago EQS-Adhoc: JENOPTIK AG: Daniela Mattheus becomes new Chairwoman of the Supervisory Board of JENOPTIK AG
Published on 12/19/2025 at 16:30, 41 minutes ago The Platform Group acquires fashion platform 43einhalb
Published on 12/19/2025 at 14:54, 2 hours 16 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 12/19/2025 at 08:30, 8 hours 41 minutes ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 8 hours 41 minutes ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 10 hours 11 minutes ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 10 hours 11 minutes ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
Published on 12/18/2025 at 18:30, 22 hours 41 minutes ago Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV
